3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Brain Neoplasms
7
Central Nervous System Neoplasms
6
Breast Neoplasms
6
Pancreatic Neoplasms
5
Glioblastoma
5
Ovarian Neoplasms
4
Neoplasms
4
Medulloblastoma
4
Glioma
4
Sarcoma
3
Prostatic Neoplasms
3
Osteosarcoma
3
Melanoma
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Neuroectodermal Tumors, Primitive
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Microphthalmia, Isolated, with Coloboma 5
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Esthesioneuroblastoma, Olfactory
2
Diffuse Intrinsic Pontine Glioma
2
Interventions
Ifosfamide
4
Filgrastim
4
Paclitaxel
3
Cisplatin
3
pegfilgrastim
2
liposomal amphotericin B
2
Therapeutics
2
Peripheral Blood Stem Cell Transplantation
2
Ipilimumab
2
Etoposide
2
CTLA-4 Antigen
2
sargramostim
1
ixabepilone
1
aldesleukin
1
Specimen Handling
1
Ribavirin
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Palivizumab
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Lenograstim
1
Itraconazole
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Interferon-alpha
1
Gemcitabine
1
Fluconazole
1
Cyclophosphamide
1
Caspofungin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seminoma
×
Gemcitabine
×
CNS
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled